Report Brief | Environmental Nexus of Brain Health | 10.5281.cjdh.16059292

The Impact of Environmental Factors on Neurological Health: A Synthesis of Current Evidence

CARE J. Public Health|Volume. 960, Issue 21|Published: May 2025 | DOI: 10.5281/zenodo.16059292

Featured in this article

This briefing synthesizes current evidence on the profound and escalating impact of environmental factors on human neurological health. It highlights that the human nervous system is highly susceptible to a wide array of external insults, leading to consequences ranging from subtle cognitive deficits to severe neurodegenerative diseases like Alzheimer's and Parkinson's. The scope of "environmental influence" extends beyond traditional pollution to include chemical contaminants, occupational hazards, physical agents (like radiation), lifestyle factors, climate change, and even ambient noise. A critical theme is that many environmental exposures, particularly during sensitive developmental periods, can cause irreversible damage due to the limited capacity for neuronal regeneration. The document details specific categories of environmental neurotoxicants, outlines the common biological mechanisms by which they cause harm, emphasizes periods of heightened vulnerability, and discusses current research challenges and future directions, ultimately advocating for comprehensive preventative strategies.

Key themes and most important ideas

I. The Environmental Nexus of Brain Health

  • Broad Definition of "Environmental" Influence: The concept of environmental influence on neurological health is expansive, encompassing "a wide array of external, extragenetic factors that can adversely affect neural structure and function." This includes "exposures to chemical contaminants in air, water, and food; occupational hazards; physical agents like radiation; lifestyle factors such as diet and physical activity; climate-related phenomena; and even ambient noise levels." (Source 1)
  • Irreversibility of Damage: Prevention is a primary objective because "many types of nervous system injury are irreversible due to the limited capacity for neuronal regeneration after initial development." (Source 1)
  • Escalating Concern: There is "escalating scientific and public health concern" regarding this relationship, underscored by "increasing rates of major neurodegenerative diseases like Alzheimer's and Parkinson's disease, alongside a substantial global burden of neurological disorders." (Source 2)


II. Key Environmental Exposures and Associated Neurological Consequences

  • Air Pollution (PM2.5, NO2): An "Invisible Threat":Ubiquitous Threat: Ambient air pollution, particularly fine particulate matter (PM2.5) and nitrogen dioxide (NO2), is a "significant and increasingly recognized threat to neurological health." (Source 9)
  • Penetration and Impact: PM2.5 can "penetrate deep into the lungs, enter the bloodstream, and subsequently reach the brain either via systemic circulation or potentially through direct transport along the olfactory nerve." (Source 5)
  • Wide Spectrum of Effects: Associated with "cognitive decline, including impaired memory and concentration, sometimes described as 'brain fog,' observed in both adults and children," increased risk or exacerbation of "Alzheimer's disease (AD) and Parkinson's disease (PD), as well as stroke." (Source 5, 9) Emerging links to "mood disorders, depression, and potentially neurodevelopmental disorders like Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) in children." (Source 5) MRI studies show "structural brain changes, such as brain atrophy." (Source 10)
  • Chemical Neurotoxicants: Pervasive Exposure:Neurotoxicity Defined: "Neurotoxicity" refers to the capacity of agents to cause "adverse functional or structural changes in the nervous system." Prevention by identifying hazards before widespread human exposure is a "fundamental principle." (Source 1, 8)
  • Pesticides: Concerns exist, particularly during critical developmental windows, with epidemiological studies exploring links to ADHD, cognitive deficits, and ASD. Examples include "chlorpyrifos metabolites and attention problems or lower IQ scores." (Source 3) Long-term exposure linked to Parkinson's disease. (Source 2)
  • Industrial Chemicals & Solvents: PCBs, PAHs, toluene, TCE, n-hexane, dichloromethane, and carbon disulfide are recognized neurotoxicants. Linked to "impaired learning, memory, IQ deficits, and behavioral issues" during development. Can lead to "acute CNS depression to chronic cognitive impairment and potentially increase the risk for neurodegenerative diseases like AD and PD." (Source 1, 2, 14) "Thousands of chemicals in commerce lack adequate testing for neurodevelopmental effects." (Source 16)
  • Endocrine Disrupting Chemicals (EDCs): Chemicals like BPA and phthalates interfere with hormonal systems, which are "critical roles in brain development and function." Exposure, especially in early development, can lead to "altered brain function, behavioral changes (e.g., aggression, hyperactivity, anxiety linked to BPA; impaired concentration or motor function linked to phthalates), and increased susceptibility to neurological diseases later in life." (Source 14)
  • Heavy Metals: Persistent Neurotoxicants:Bioaccumulation: Metals like lead (Pb), mercury (Hg), arsenic (As), cadmium (Cd), manganese (Mn), aluminum (Al), and nickel (Ni) are neurotoxic and "tend to bioaccumulate—meaning they are absorbed faster than they can be eliminated." (Source 19)
  • Specific Impacts:Lead (Pb): "Particularly damaging to the developing nervous system." Linked to "irreversible cognitive impairments, reduced IQ, learning disabilities, and behavioral problems." May increase AD risk. (Source 1, 2)
  • Mercury (Hg): Especially methylmercury, "readily crosses the blood-brain barrier." High exposures cause "severe neurological damage (Minamata disease)." Prenatal exposure can impair visual processing. (Source 19, 20)
  • Manganese (Mn): Excess linked to "Parkinsonism-like syndrome." (Source 1)
  • Aluminum (Al): Role in AD "under investigation," found "co-localized with amyloid plaques and neurofibrillary tangles" and may influence amyloid-beta aggregation. (Source 2)
  • Glial Cell Damage: A critical aspect is their impact on glial cells (microglia, astrocytes, oligodendrocytes), which are "particularly vulnerable to metal-induced damage." This can lead to "neuroinflammation, disrupt astrocyte functions... and impair oligodendrocyte function leading to demyelination." (Source 18)
  • Climate Change: A "Threat Multiplier":Direct and Indirect Impacts: "Acting often as a threat multiplier," impacts stem from "rising average and extreme temperatures, increased humidity, and more frequent and intense extreme weather events," as well as "indirectly through worsening air quality." (Source 4)
  • Neurological Consequences: Extreme heat can "disrupt sleep patterns," which exacerbates epilepsy and contributes to cognitive decline. Increases "incidence and mortality from stroke." Worsens MS symptoms and increases hospital admissions for dementia. (Source 4, 6)
  • Vulnerable Populations: "Disproportionately affected" are "low-income countries, the elderly, children, and individuals with pre-existing neurological or cardiovascular conditions." (Source 6)
  • Other Environmental Influences:Noise Pollution: Chronic exposure linked to "increased stress levels, anxiety, depression, and significant sleep disturbances," indirectly impacting neurological well-being. Also linked to "cognitive impairment, particularly affecting cognitive development and academic performance in children." (Source 7)
  • Lifestyle Factors: Diet and physical activity, influenced by the environment, are critical. Healthy diet and regular activity "support cognitive functions" and improve "mood, stress resilience, and overall brain health." (Source 5)
  • Infections: Environmental conditions, including climate change (altering vector ranges), play a role in the transmission of infectious agents that can have neurological sequelae. (Source 4)


III. Mechanisms of Environmental Neurotoxicity: Common Pathways of Damage


Diverse environmental agents often trigger a "limited number of common biological pathways within the nervous system." (Source 2)


  • Oxidative Stress: An imbalance between reactive oxygen species (ROS) and antioxidant defenses, leading to damage to "lipids (lipid peroxidation), proteins, and DNA within neurons and glial cells." Contributes to neuroinflammation and neurodegenerative diseases. (Source 2, 9, 18)
  • Neuroinflammation: Activation of the brain's immune cells (microglia, astrocytes) by exposures like air pollutants and heavy metals, releasing "inflammatory mediators." Chronic neuroinflammation is "detrimental," leading to neuronal dysfunction and cell death. (Source 9, 18)
  • Blood-Brain Barrier (BBB) Disruption: Environmental exposures (e.g., air pollution, heavy metals) can compromise the BBB's integrity, allowing "potentially neurotoxic substances, peripheral inflammatory cells, and harmful molecules from the circulation to enter the brain." (Source 2)
  • Mitochondrial Dysfunction: Impairment of mitochondria by toxicants (heavy metals, pesticides, air pollution components) leads to "reduced ATP production, increased generation of ROS, disruptions in calcium homeostasis, and the initiation of apoptotic pathways." Strongly implicated in neurodegenerative diseases like Parkinson's. (Source 2)
  • Neurotransmitter System Interference: Toxicants can disrupt the synthesis, storage, release, receptor binding, or reuptake/degradation of key neurotransmitters (e.g., dopamine, serotonin, acetylcholine, glutamate), underlying "cognitive, behavioral, and motor deficits." (Source 2, 14, 19)
  • Protein Misfolding and Aggregation: Certain environmental exposures (e.g., heavy metals, rotenone) can promote the accumulation of misfolded proteins, a hallmark of neurodegenerative diseases like AD (amyloid-beta, tau) and PD (alpha-synuclein). (Source 2, 19)
  • Epigenetic Modifications: Toxicants can alter gene expression without changing DNA sequence, potentially leading to "long-lasting changes in gene expression patterns relevant to brain development, neuronal function, and susceptibility to neurological disease." May explain how early-life exposures manifest later. (Source 20, 23)
  • Endocrine Disruption: EDCs interfere with hormones critical for brain development and function, particularly during "sensitive developmental windows," leading to "lasting neurological and behavioral consequences." (Source 14)
  • Interconnected Pathways: These mechanisms are "often deeply interconnected," meaning insults can "initiate a cascade of detrimental events, amplifying the initial damage." (Source 2, 9, 14, 19, 23)


IV. Vulnerability and Susceptibility: Windows of Sensitivity and Modifying Factors

  • Critical Windows of Development: The "developing nervous system, from gestation through early childhood, exhibits profound sensitivity to environmental insults." Exposure during these periods can disrupt "neurogenesis, migration, differentiation, synaptogenesis, and myelination," leading to neurodevelopmental disorders or "increasing susceptibility to neurological or psychiatric disorders that emerge only later in life." (Source 1, 3, 13, 16)
  • Aging and Neurodegeneration: Aging brains can have "reduced antioxidant capacity, altered immune function, and potentially compromised BBB integrity," lowering the threshold for environmental triggers of neurodegeneration. Cumulative lifetime exposures contribute to age-related disease risk. (Source 2, 10, 19)
  • Genetic Predisposition: Individual genetic makeup influences "absorption, distribution, metabolism, and excretion of toxicants, as well as the efficiency of DNA repair mechanisms, antioxidant defenses, and inflammatory responses." (Source 2)
  • Socioeconomic Factors and Disparities: Risks are "distributed inequitably." Low-income communities and certain occupational groups often experience "significantly higher levels of exposure." Factors like "inadequate housing, poorer nutrition, limited access to quality healthcare, and higher levels of chronic psychosocial stress" exacerbate vulnerability. (Source 3, 6)


V. Research Landscape, Challenges, and Future Directions

  • Key Challenges:Establishing Causality: Difficult due to "long latency periods," "complex mixtures," "confounding factors," and ethical constraints. (Source 2)
  • Exposure Assessment: Challenging to "accurately quantifying individual exposures, especially low-level chronic exposures over critical developmental periods or decades." (Source 3)
  • Mixture Effects: Understanding combined effects (additive, synergistic, antagonistic) is complex and "largely understudied." (Source 14)
  • Low-Dose Effects: Uncertainty exists regarding "health impacts of chronic, low-level exposures." (Source 3)
  • Data Gaps: "Thousands of chemicals...lack adequate testing for neurotoxicity, particularly developmental neurotoxicity." Less than 1% evaluated for DNT. (Source 8, 16)
  • New Approach Methodologies (NAMs):Addressing Limitations: NAMs aim to be "faster, more cost-effective, and potentially more relevant to human biology" than traditional testing. (Source 8)
  • Examples: High-Throughput In Vitro Screening, Alternative Animal Models (e.g., zebrafish), Computational Toxicology & Virtual Models, Adverse Outcome Pathways (AOPs). (Source 16)
  • Future Research Needs: Focus on mechanisms, improved exposure assessment (biomarkers, mixture models), longitudinal studies (especially from early life), gene-environment interactions, specific impacts of pesticides/air pollution, climate change impacts, and NAM validation/integration. (Source 3, 4, 6, 11)


VI. Conclusion and Recommendations


The evidence "compellingly demonstrates that a wide array of environmental factors exerts significant influence on neurological health throughout the human lifespan." (Source 1) Neurological diseases stemming from environmental factors are, by definition, preventable. (Source 8)


Recommendations:

  • Policy & Regulation:Implement and enforce "stricter regulations to limit population exposure to known and suspected neurotoxicants, including air pollutants (PM2.5, NO2), heavy metals (Pb, Hg, As), pesticides... and industrial chemicals." (Source 8)
  • "Strengthen requirements for premarket testing of new and existing chemicals specifically for neurotoxicity, with an emphasis on developmental neurotoxicity." (Source 8)
  • Integrate "climate change impacts on neurological health into national and international public health strategies." (Source 6)
  • Promote policies to "reduce community noise pollution." (Source 7)
  • Public Health Interventions:Develop initiatives to "reduce exposures, such as promoting clean energy, ensuring access to safe drinking water, remediating contaminated sites, and creating healthier community environments." (Source 4)
  • Increase public awareness and empower individuals with knowledge about "protective measures." (Source 5)
  • Prioritize interventions for "vulnerable populations, including children, pregnant women, the elderly, and socioeconomically disadvantaged communities." (Source 6)
  • Clinical Practice:Encourage healthcare providers to "incorporate environmental exposure histories into patient assessments." (Source 2)
  • Enhance clinician education on environmental risk factors and exposure reduction strategies.
  • Research:Sustain and expand research on "mechanisms of environmental neurotoxicity, assess the effects of chemical mixtures, improve exposure assessment techniques, investigate gene-environment interactions, and clarify the links between specific exposures and outcomes." (Source 4)
  • Support "longitudinal studies and the continued development and validation of New Approach Methodologies (NAMs)."

References
  1. Introduction: Defining the Problem of Neurotoxicity - Environmental ..., accessed May 12, 2025, https://www.ncbi.nlm.nih.gov/books/NBK234243/

  2. The Role of Environmental Exposures in Neurodegeneration and ..., accessed May 12, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3216414/

  3. Pesticide Exposure and Neurodevelopmental Outcomes: Review of ..., accessed May 12, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3705499/

  4. The Effects of Climate Change on Brain Disease | American Brain ..., accessed May 12, 2025, https://www.americanbrainfoundation.org/the-effects-of-climate-change-on-brain-disease/

  5. Environmental Influences on Neurological Disorders, accessed May 12, 2025, https://lonestarneurology.net/others/environmental-factors-and-their-role-in-neurological-disorders/

  6. Climate change poses growing threat to neurological health, new ..., accessed May 12, 2025, https://www.ucl.ac.uk/brain-sciences/news/2025/feb/climate-change-poses-growing-threat-neurological-health-new-review-warns

  7. (PDF) NOISE POLLUTION AND ITS EFFECTS ON HUMAN HEALTH: A REVIEW, accessed May 12, 2025, https://www.researchgate.net/publication/385655327_NOISE_POLLUTION_AND_ITS_EFFECTS_ON_HUMAN_HEALTH_A_REVIEW

  8. Testing for Neurotoxicity - Environmental Neurotoxicology - NCBI Bookshelf, accessed May 12, 2025, https://www.ncbi.nlm.nih.gov/books/NBK234247/

  9. Air pollution and neurological diseases, current state highlights - PMC, accessed May 12, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10950980/

  10. Air Pollution and Brain Health | Environmental Health Sciences Center, accessed May 12, 2025, https://environmentalhealth.ucdavis.edu/air-pollution/brain-health

  11. A Systematic Review of Air Pollution Exposure and Brain Structure and Function during Development | medRxiv, accessed May 12, 2025, https://www.medrxiv.org/content/10.1101/2024.09.13.24313629v1

  12. The Effects of Air Pollution on Neurological Diseases: A Narrative Review on Causes and Mechanisms - MDPI, accessed May 12, 2025, https://www.mdpi.com/2305-6304/13/3/207

  13. Environmental Exposure to Pesticides and the Risk of Child Neurodevelopmental Disorders, accessed May 12, 2025, https://www.mdpi.com/1648-9144/60/3/475

  14. Elucidating the Links Between Endocrine Disruptors and Neurodevelopment - PMC, accessed May 12, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5393340/

  15. NEURO: Human Neurotoxicants - CompTox Chemicals Dashboard - Environmental Protection Agency, accessed May 12, 2025, https://comptox.epa.gov/dashboard/chemical_lists/humanneurotox

  16. www.epa.gov, accessed May 12, 2025, https://www.epa.gov/system/files/documents/2022-10/DNT_Factsheet_10_28_22_Final_1.pdf

  17. Overview of Endocrine Disruption | US EPA, accessed May 12, 2025, https://www.epa.gov/endocrine-disruption/overview-endocrine-disruption

  18. Glial Perturbation in Metal Neurotoxicity: Implications for Brain ..., accessed May 12, 2025, https://www.mdpi.com/2571-6980/6/1/4

  19. Heavy Metal Exposure and ... - Healthspan Research Review, accessed May 12, 2025, https://gethealthspan.com/science/article/heavy-metal-exposure-neurological-health-longevity

  20. Neurodegenerative Diseases: Implications of Environmental and ..., accessed May 12, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9564880/

  21. Climate change is fueling a neurological health crisis, experts warn - News-Medical.net, accessed May 12, 2025, https://www.news-medical.net/news/20250121/Climate-change-is-fueling-a-neurological-health-crisis-experts-warn.aspx

  22. Noise Pollution and Health - Public Health Post, accessed May 12, 2025, https://publichealthpost.org/environment/noise-pollution-and-health/

  23. Epigenetic influence of environmentally neurotoxic metals - PMC - PubMed Central, accessed May 12, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7708394/

  24. Emerging Roles of Histone modifications in Environmental Toxicants-Induced Neurotoxicity, accessed May 12, 2025, https://pubmed.ncbi.nlm.nih.gov/40286899/

Funding & Ethical Disclosures

Funding Sources

The authors would like to acknowledge the support of the Google for Startups Founders Fund, which provided financial resources and support for this research.

Copyright Notice

By accessing a podcast or webcast (collectively the "Products"), you acknowledge that the contents, design, and materials are the property of the CONCIERCARE Scientific Publishing Group (CSPG) or used by CSPG with permission. The Products and their data, content, information, and other materials are protected under United States and international copyright and trademark laws. Except as otherwise provided herein, users of the Products may save and use information contained therein only for personal or other noncommercial, educational purposes. No other use, including, without limitation, reproduction, retransmission, or editing, may be made without the prior written permission of CSPG, which may be requested by contacting the Clinical Library Network at 105hig1.clinicallibrarynetwork@conciercare.net.

Disclaimer

The Products and content contained therein, including text, images, audio, or other formats, were created for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. If you think you may have a medical emergency, call your physician, go to the emergency department, or call 911 immediately. CSPG does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided is solely at your own risk.


Furthermore, any third-party materials or content of any third-party site referenced in the Products do not necessarily reflect the opinions, standards, or policies of CSPG. CSPG assumes no responsibility or liability for the accuracy or completeness of the content contained in third-party materials or on third-party sites referenced in this podcast or the compliance with applicable laws of such materials and/or links referenced therein.

Transcripts may be automatically generated and not reviewed for accuracy. Please note that transcriptions may contain errors, including incorrect medical terminology or misinterpretations of the spoken content. For the most accurate information, please refer to the official podcast audio.

Limitation of Liability

CSPG expressly disclaims any and all liability or responsibility for any direct, indirect, incidental, special, consequential, or other damages, including, without limitation, loss of profits arising out of any individual's use of, reference to, reliance on, or inability to use the products or the information presented in the Products.

Supplementary Material
Glossary of Key Terms

  • Alzheimer's Disease (AD): A progressive neurodegenerative disease that causes problems with memory, thinking, and behavior, linked to amyloid plaques and tau tangles in the brain.
  • Amyotrophic Lateral Sclerosis (ALS): A progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control.
  • Antioxidant Defenses: The body's systems, including enzymes and molecules like glutathione, that neutralize reactive oxygen species (ROS) and protect cells from oxidative damage.
  • Apoptosis: Programmed cell death, a normal process of cell turnover that can be triggered abnormally by neurotoxicants.
  • Astrocytes: Star-shaped glial cells in the brain and spinal cord that support neurons, maintain the blood-brain barrier, and regulate neurotransmitter levels.
  • Attention Deficit Hyperactivity Disorder (ADHD): A neurodevelopmental disorder characterized by difficulties with attention, hyperactivity, and impulsivity.
  • Autism Spectrum Disorder (ASD): A neurodevelopmental condition characterized by challenges with social skills, repetitive behaviors, speech, and nonverbal communication.
  • Bioaccumulation: The process by which substances, such as heavy metals, are absorbed by an organism faster than they are eliminated, leading to an increase in concentration in tissues over time.
  • Blood-Brain Barrier (BBB): A highly selective semipermeable border of endothelial cells that prevents solutes in the circulating blood from non-selectively diffusing into the extracellular fluid of the central nervous system.
  • Carbamates: A class of pesticides that affect the nervous system, often by inhibiting cholinesterase enzymes.
  • Chelation Therapy: A medical procedure that involves the administration of chelating agents to remove heavy metals from the body.
  • Chlorpyrifos: An organophosphate pesticide linked to potential neurodevelopmental effects.
  • Cognitive Decline: A reduction in mental abilities, such as memory, thinking, and reasoning, that is more significant than expected for a person's age.
  • Confounding Factors: External variables that can influence both the exposure and the outcome, potentially distorting the observed relationship between them.
  • DALYs (Disability-Adjusted Life Years): A measure of overall disease burden, expressed as the number of years lost due to ill-health, disability, or early death.
  • DDT (Dichlorodiphenyltrichloroethane): An organochlorine pesticide, now largely banned, with known environmental persistence and potential neurotoxic effects.
  • Demyelination: Damage to the myelin sheath, the fatty covering that insulates nerve fibers, leading to impaired nerve signal transmission.
  • Developmental Neurotoxicity (DNT): Adverse functional or structural changes in the developing nervous system resulting from exposure to chemical, physical, or biological agents.
  • Endocrine Disrupting Chemicals (EDCs): Chemicals that interfere with the body's endocrine (hormone) system, producing adverse developmental, reproductive, neurological, and immune effects.
  • Epigenetic Modifications: Heritable changes in gene expression that do not involve alterations to the underlying DNA sequence, such as DNA methylation and histone modifications.
  • Glial Cells: Non-neuronal cells in the central and peripheral nervous systems that provide support, nourishment, and protection to neurons (includes microglia, astrocytes, oligodendrocytes).
  • High-Throughput In Vitro Screening: Automated laboratory methods used to test large numbers of chemicals for specific biological activities on cultured cells or tissues.
  • Histone Acetylation/Methylation: Epigenetic modifications involving the addition of acetyl or methyl groups to histone proteins, which can alter gene expression.
  • Longitudinal Studies: Research studies that observe the same subjects over long periods, often years or decades, to track changes and identify long-term associations.
  • Microglia: Resident immune cells of the central nervous system that act as the brain's primary form of active immune defense.
  • Mitochondrial Dysfunction: Impaired function of mitochondria, the organelles responsible for energy production (ATP) in cells, leading to reduced energy, increased reactive oxygen species, and cell death.
  • Myelination: The process of forming a myelin sheath around a nerve to allow nerve impulses to move more quickly.
  • New Approach Methodologies (NAMs): Modern scientific methods and tools used for chemical hazard and risk assessment that can be faster, more efficient, and more human-relevant than traditional animal testing.
  • Neurogenesis: The process by which new neurons are formed in the brain.
  • Neuroinflammation: Inflammation occurring within the central nervous system, often involving activated glial cells and the release of inflammatory mediators.
  • Neuronal Regeneration: The capacity of neurons to regrow or repair themselves after injury, which is limited in the adult mammalian nervous system.
  • Neurosygenosis: The formation of new synapses (connections) between neurons.
  • Neurotransmitter Interference: Disruption of the chemical signaling process between neurons, affecting the synthesis, release, binding, or breakdown of neurotransmitters like dopamine, serotonin, or acetylcholine.
  • Nitrogen Dioxide (NO2): A common air pollutant, primarily from vehicle exhaust, linked to cognitive decline and neurodegenerative processes.
  • Oligodendrocytes: Glial cells in the central nervous system that produce myelin, the insulating sheath around nerve fibers.
  • Organochlorines: A class of persistent pesticides (e.g., DDT) known for their environmental stability and neurotoxic effects.
  • Organophosphates: A class of pesticides (e.g., chlorpyrifos) that inhibit enzymes critical for nervous system function, such as acetylcholinesterase.
  • Oxidative Stress: An imbalance between the production of reactive oxygen species (ROS) and the body's ability to detoxify them, leading to cellular damage.
  • Parkinson's Disease (PD): A progressive neurodegenerative disorder characterized by motor symptoms (tremor, rigidity, slow movement) and non-motor symptoms, linked to the loss of dopamine-producing neurons and alpha-synuclein aggregates.
  • Particulate Matter (PM2.5): Fine inhalable particles with diameters generally 2.5 micrometers and smaller, a major component of air pollution that can penetrate deep into the lungs and bloodstream.
  • Phthalates: A group of chemicals used to make plastics more flexible and durable; considered endocrine disruptors with potential neurodevelopmental effects.
  • Polychlorinated Biphenyls (PCBs): Industrial chemicals, now banned, that were used as coolants and plasticizers, known neurotoxicants and endocrine disruptors.
  • Polycyclic Aromatic Hydrocarbons (PAHs): Chemicals that occur naturally in coal, crude oil, and gasoline, and are products of incomplete combustion (e.g., from vehicle exhaust, wildfires); some are neurotoxic.
  • Protein Misfolding and Aggregation: The process where proteins fold incorrectly and clump together, forming insoluble aggregates that are characteristic hallmarks of many neurodegenerative diseases.
  • Pyrethroids: A class of synthetic pesticides developed as synthetic versions of natural insecticides found in chrysanthemums.
  • Reactive Oxygen Species (ROS): Highly reactive molecules containing oxygen, such as free radicals, generated during normal metabolism or in response to stress, which can cause cellular damage.
  • Rotenone: A naturally occurring pesticide that inhibits mitochondrial complex I, used in research to induce Parkinson's-like pathology.
  • Synaptogenesis: The formation of synapses between neurons, a critical process in brain development.
  • Tau Protein: A protein that helps stabilize microtubules, a component of the cell's cytoskeleton. In Alzheimer's disease, tau becomes hyperphosphorylated and forms neurofibrillary tangles.
  • Toxic Substances Control Act (TSCA): A U.S. law that regulates the introduction of new or already existing chemicals.
  • Trichloroethylene (TCE): A colorless liquid, commonly used as an industrial solvent, known to be a neurotoxicant.

Video/Podcasts
Book a Consultation
Contributors

Hosted by

SEPHAIRA Virtual Health Coordinator


Reporting by

Various


Senior Managing Producer

Rajendra Singh


Edited by

Podcast Script by Notebook LM


Animation by

Creative Commons and Gemini/VEO AI


Senior Director of Video

Rajendra Singh


Additional Footage

Images via Creative Commons and Gemini/VEO AI


Additional Sources

See references below

Episode Resources

  1. World Health Organization (WHO):

As the primary source for the definition and conceptual framework of SDOH cited throughout the paper, the WHO website is the best starting point for global perspectives. It offers foundational reports, data, and explanations of how factors like economic stability and education impact health equity worldwide.


The CDC is a key source for understanding SDOH within the United States. Their website provides extensive information, data, and resources, including the Healthy People initiative, which sets data-driven national objectives to improve health and well-being, with a strong focus on SDOH.

3. Academic Research Databases (e.g., PubMed, Google Scholar):

The paper's bibliography references numerous academic journals. For readers who want to dive deeper into the primary research, databases like PubMed (for health and medical sciences) and Google Scholar are invaluable. You can search for terms like "Social Determinants of Health," "health equity," or "AI in public health" to find the latest studies.

4. Local Public Health Department:

A local public health department is a physical place where you can learn how SDOH are being addressed in your specific community. They often provide pamphlets, reports, local health data, and information on programs related to food security, housing, and healthcare access.

5. University Libraries, especially a School of Public Health:

University libraries are excellent physical resources that provide access to a vast collection of books, academic journals, and databases. Librarians can also provide expert assistance in finding information. A university with a public health, medical, or sociology department is particularly likely to have extensive resources on SDOH.
Related Articles